BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10676911)

  • 1. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.
    Frickhofen N; Rosenfeld SJ
    Semin Hematol; 2000 Jan; 37(1):56-68. PubMed ID: 10676911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
    Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
    Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
    Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
    Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Chandra J; Naithani R; Ravi R; Singh V; Narayan S; Sharma S; Pemde H; Dutta AK
    Indian J Pediatr; 2008 Mar; 75(3):229-33. PubMed ID: 18376089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
    He G; Zhang X; Wu D; Sun A; Wang X
    Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Gupta V; Bhatia B
    Indian J Pediatr; 2009 Sep; 76(9):970-1; author reply 971-2. PubMed ID: 19381516
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
    Scheinberg P; Wu CO; Nunez O; Young NS
    J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
    Fang JP; Xu HG; Huang SL; Chen C; Huang K
    Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
    Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy for aplastic anemia--review].
    Xu CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reference guide for the treatment of aplastic anemia: key points of the 2022 revision].
    Yamazaki H
    Rinsho Ketsueki; 2023; 64(9):892-899. PubMed ID: 37793863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
    Sharma R; Chandra J; Sharma S; Pemde H; Singh V
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
    Risitano AM
    Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.